Analyst Expectations for Kiora Pharmaceuticals's Future
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Kiora Pharmaceuticals (NASDAQ:KPRX) in the last quarter, with 4 total ratings. The average 12-month price target for Kiora Pharmaceuticals is $2.38, a 66.0% decrease from the previous average price target of $7.00.
November 06, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Kiora Pharmaceuticals has received bullish ratings from analysts, but the average 12-month price target has decreased significantly.
While the company has received positive ratings from analysts, the significant decrease in the average 12-month price target could indicate a potential decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100